28 أبريل #advanced #Cancer #capecitabine #combination #gastric #irinotecan #metastatic #role #therapy Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer by Dr. Fadi Farhat 0
07 أبريل #advanced #capecitabine #combination #gastric cancer #irinotecan #metastatic #role #therapy Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer by Dr. Fadi Farhat 0
04 مارس #adult #carcinoma #case report #down's #Patient #syndrome #Tongue Tongue carcinoma in an adult Down’s syndrome patient: a case report by Dr. Fadi Farhat 0
21 ديسمبر #adolescents #bone #children #developing country #Limb #malignant #salvage #surgery #tumor Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country by Dr. Fadi Farhat 0
21 يونيو #advanced #breast cancer #capecitabine #Docetaxel #long-term #Phase II #pilot #sequential #trial #vinorelbine Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial. by Dr. Fadi Farhat 0
18 مايو #early #effects #late #mustard #respiratory #severity #sulfur #symptoms Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? by Dr. Fadi Farhat 0
23 أبريل #approach #artery #axillary #impella #LP 5.0 microaxial pump #recover #right The right axillary artery approach for the Impella Recover LP 5.0 microaxial pump by Dr. Fadi Farhat 0
23 فبراير #Cancer #Docetaxel #estramustine #hormone #HRPC #prostate #refractory #weekly #zolendronic acid Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC) by Dr. Fadi Farhat 0
18 يناير #acute myeloid leukemia #AML #haemochromatosis #Kodamaea #ohmeri fungaemia #Patient #pichia Kodamaea (Pichia) ohmeri fungaemia complicating acute myeloid leukaemia in a patient with haemochromatosis by Dr. Fadi Farhat 0
14 يناير #advanced #Chemotherapy #Docetaxel #first-line #irinotecan #NSCLC #patients #pilot #study Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study by Dr. Fadi Farhat 0
